Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin-induced Thrombosis”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06494878
What this trial is testing

The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity

Who this might be right for
Venous ThromboembolismPostpartum PeriodAspirin+1 more
University of Calgary 8,805
Not applicableStudy completedNCT01378000
What this trial is testing

Study on Continuous Intravenous of Unfractionated Heparin (UFH) to Treat Progressive Cerebral Infarction

Who this might be right for
Heparin Causing Adverse Effects in Therapeutic UseHeparin-induced ThrombosisAcute Cerebral Ischemia
Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine 480
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Not applicableStudy completedNCT00283322
What this trial is testing

Heparin Antibodies in Intensive Care Unit Patients (HAICU)

Who this might be right for
Heparin-Induced Thrombocytopenia
The University of Texas Health Science Center, Houston 185
Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Not applicableUnknownNCT03269019
What this trial is testing

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
Wuhan Asia Heart Hospital 200
Large-scale testing (Phase 3)Study completedNCT00043940
What this trial is testing

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
The Medicines Company 50
Large-scale testing (Phase 3)Study completedNCT00079508
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Who this might be right for
Cardiovascular DiseaseCoronary Artery Bypass Surgery
The Medicines Company 125
Post-approval studies (Phase 4)Enrolling By InvitationNCT03244020
What this trial is testing

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Who this might be right for
SarcomaSoft Tissue SarcomaBone Sarcoma+4 more
Massachusetts General Hospital 2,868
Post-approval studies (Phase 4)Study completedNCT00913133
What this trial is testing

Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis

Who this might be right for
Thrombosis
Canyon Pharmaceuticals, Inc. 516
Post-approval studies (Phase 4)UnknownNCT00196417
What this trial is testing

The HIT-TRAP Trial

Who this might be right for
Heparin-Induced Thrombocytopenia
University Medicine Greifswald 600
Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Early research (Phase 1)Study completedNCT00412464
What this trial is testing

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Who this might be right for
ThrombosisHeparin-induced Thrombocytopenia
Children's Hospital Los Angeles 24
Not applicableStudy completedNCT00456326
What this trial is testing

Heparin-Induced Thrombocytopenia Registry

Who this might be right for
Heparin-Induced Thrombocytopenia
Brigham and Women's Hospital 242
Not applicableEnded earlyNCT00594685
What this trial is testing

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Who this might be right for
Thrombocytopenia
Carelon Research 10
Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Not applicableStudy completedNCT00456001
What this trial is testing

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Brigham and Women's Hospital 200
Not applicableStudy completedNCT00748839
What this trial is testing

Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Saint Etienne 2,700
Not applicableUnknownNCT01102790
What this trial is testing

Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
Johann Wolfgang Goethe University Hospital 160
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Load More Results